Study to Check the Efficacy and Safety of Recombinant BCG Vaccine in Prevention of TB Recurrence

NCT03152903 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

2000

Enrollment

INDUSTRY

Sponsor class

Conditions

Prevention of TB Recurrence

Interventions

BIOLOGICAL: VPM1002 (Recombinant BCG Vaccine)
OTHER: Placebo

Sponsor

Serum Institute of India Pvt. Ltd.